U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806552) titled 'Middle Meningeal Artery Embolization in Patients With Chronic Subdural Hematoma' on Aug. 30.
Brief Summary: Primary : to evaluate the efficacy of MMAE on resolution and recurrence of hematoma in patients with CSDH.
Secondary : evaluate the effect of MMAE on functional outcome, radiological changes, the need to repeat surgery, duration of hospital stay, time for hematoma to resolve.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Middle Meningeal Artery Embolization
Chronic Subdural Hematomas
Intervention:
PROCEDURE: middle meningeal artery embolization
Middle meningeal artery (MMA) embolization is a minimall...